In addition to nausea and vomiting, people taking GLP-1 drugs can experience altered bowel habits due to the slowed motility of the gut
rotate injection sites with each dose
From combination therapies that preserve muscle mass, to oral agents breaking bioavailability barriers, and dual-agonists redefining treatment strategieseach advancement marks a critical step forward for the millions living with obesity and type 2 diabetes
The information we receive from these sources may include, but is not limited to, identifiers, demographics, education information, address information, Internet or other electronic network activity, and inferences about your preferences or other characteristics
Our sophisticated approach to GLP-1 medication monitoring reflects our commitment to staying ahead of emerging developments in eye care